Neuroendocrine carcinoma of the skin
Not recruitingStudy of Retifanlimab Combined with Carboplatin, Cisplatin and Etoposide Before Surgery in Patients with Resectable Merkel Cell Carcinoma
Study of Retifanlimab Combined with Carboplatin, Cisplatin and Etoposide Before Surgery in Patients with Resectable Merkel Cell Carcinoma
- Disease:Neuroendocrine carcinoma of the skin
- Substances:CarboplatinCisplatin+2
Italy- Participants:18–64 years · 65+ years
- Substances:Carboplatin
- Sponsor:Gruppo Oncologico Del Nord Ovest









